Skip to main content
. 2016 Jun 14;11(6):e0156229. doi: 10.1371/journal.pone.0156229

Fig 5. AM0010 treatment enhances Kupffer cell phagocytosis of LDL and VLDL particles.

Fig 5

(A), primary human monocytes, (B), primary human macrophages, (C), primary human Kupffer cells and (D), human hepatocytes lipoprotein uptake with or without 24 hr. treatment of 100ng/mL PEG-rHuIL-10. (E-F) inhibition of LDL and VLDL uptake by Cytochalasin D. Each experiment represents 3–12 independent experiments. Background (b.g.) means cells without lipoprotein addition. Statistics for (A-F) were assessed by Students t-test where *p<0.05 and **p<0.01.